![Adrian Howd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrian Howd
Finansdirektör/CFO på
BIVICTRIX THERAPEUTICS PLC
Profil
Adrian G.
Howd is currently the Director at Viamet Pharmaceuticals, Inc., Independent Director at Viamet Pharmaceuticals Corp., Director & Principal at Brandon Point Industries Ltd., Director at Blueberry Therapeutics Ltd., and will be the Chief Financial & Business Officer at BiVictriX Therapeutics Plc starting in 2023.
Previously, he was the Chief Executive Officer at Malin Corp.
Plc from 2015 to 2018.
He also served as a Non-Executive Director at Kymab Ltd., Director at Poseida Therapeutics, Inc., Director at Wavebreak Therapeutics Ltd. from 2016 to 2018, Non-Executive Director at Immunocore Holdings Plc, and Executive Vice President at Evotec SE.
Dr. Howd started his career as a Research Analyst at ABN AMRO Bank NV (London Branch) in 2008 and later worked as a Research Analyst at Joh.
Berenberg, Gossler & Co. KG (United Kingdom) from 2009 to 2013.
He holds a doctorate degree from the University of London.
Aktiva positioner av Adrian Howd
| Företag | Position | Start |
|---|---|---|
| BIVICTRIX THERAPEUTICS PLC | Finansdirektör/CFO | 2023-10-03 |
Brandon Point Industries Ltd.
 Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Operates as a life sciences company | Direktör/Styrelseledamot | - |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Direktör/Styrelseledamot | - |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Direktör/Styrelseledamot | - |
Blueberry Therapeutics Ltd.
 Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug research and development | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Adrian Howd
| Företag | Position | Slut |
|---|---|---|
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Direktör/Styrelseledamot | 2018-10-28 |
| MALIN CORPORATION PLC | Verkställande Direktör | 2015-08-24 |
Joh. Berenberg, Gossler & Co. KG (United Kingdom)
 Joh. Berenberg, Gossler & Co. KG (United Kingdom) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2013-06-01 |
ABN AMRO Bank NV (London Branch) (Broker) (Old)
 ABN AMRO Bank NV (London Branch) (Broker) (Old) Regional BanksFinance Commercial foreign bank. | Analyst-Equity | 2008-04-16 |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Adrian Howds utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
72
Första gradens relationer
14
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 14 |
|---|---|
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Health Technology |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Health Technology |
Malin Corp. Plc
 Malin Corp. Plc BiotechnologyHealth Technology Provides life science services | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
ABN AMRO Bank NV (London Branch) (Broker) (Old)
ABN AMRO Bank NV (London Branch) (Broker) (Old) Regional BanksFinance Commercial foreign bank. | Finance |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Joh. Berenberg, Gossler & Co. KG (United Kingdom)
Joh. Berenberg, Gossler & Co. KG (United Kingdom) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Brandon Point Industries Ltd.
Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Operates as a life sciences company | Health Services |
Blueberry Therapeutics Ltd.
Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug research and development | Health Technology |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Health Technology |
BiVictriX Therapeutics Plc
 BiVictriX Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and distributes cancer therapeutics | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
